Questions? Call Us (800) 462-3183

Skip to content

Cannabis & Cancer Care: Oncology's Green Revolution

by Rolling Stone Culture Council / Cannabis

Oncology is ever-evolving, with new treatments, therapies, and innovations emerging yearly. However, one of the most intriguing and controversial developments in recent times is the growing use of cannabis in cancer care. 

Once stigmatized and criminalized, cannabis is now gaining attention as a complementary therapy in oncology, offering potential benefits for symptom management, pain relief, and possibly even cancer treatment itself.

So, how exactly does cannabis intersect with oncology? And what should patients, caregivers, and healthcare professionals know about this powerful plant and its potential role in cancer care?

The Science Behind Cannabis & Cancer

To understand the impact of cannabis in oncology, we first need to dive into the plant’s unique chemical compounds—primarily cannabinoids. 

The two most studied cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is responsible for the psychoactive effects of cannabis, while CBD is non-psychoactive and has gained popularity for its potential therapeutic properties.

The endocannabinoid system (ECS), present in every human body, is crucial in maintaining balance in various physiological processes, including pain, mood, appetite, and immune function. Cannabinoids, like THC and CBD, interact with this system by binding to cannabinoid receptors (CB1 and CB2), which can have far-reaching effects on health and wellness.

Research into cannabis and cancer has revealed a range of potential uses, from managing the side effects of chemotherapy to possibly inhibiting the growth of cancer cells. While much more research is needed to understand these mechanisms fully, the evidence is promising.


Managing Symptoms With Cannabis

One of the most well-known applications of cannabis in oncology is its ability to help manage the symptoms and side effects of cancer treatment. 

Chemotherapy, radiation, and other cancer therapies can lead to a variety of debilitating symptoms, including nausea, vomiting, loss of appetite, chronic pain, and insomnia. For many patients, these symptoms are as challenging as the cancer itself.

Cannabis, particularly strains high in THC, has been shown to combat chemotherapy-induced nausea and vomiting effectively. Several studies suggest that cannabis may be more effective than traditional antiemetics in some patients. THC can also stimulate appetite, which is crucial for patients dealing with weight loss and malnutrition due to cancer treatment.

Chronic pain management is another critical area where cannabis shows promise. Cancer pain can be complex, often involving inflammation, nerve damage, and pressure on internal organs. Cannabis—especially when using both THC and CBD—can help reduce pain and improve the quality of life for patients. 

Overall, data highlights the need for more clinical studies to optimize cannabinoid ratios and adjust dosages to achieve the maximum analgesic effect.

Beyond managing physical symptoms, cannabis can also have psychological benefits. Cancer patients often face anxiety, depression, and insomnia, all of which can negatively impact their treatment outcomes and overall well-being. By promoting relaxation and improving sleep, cannabis can help alleviate these psychological burdens, allowing patients to focus on their recovery.


Cannabinoids & Cancer Treatment: What the Research Says

While the use of cannabis for symptom management is widely accepted in many parts of the world, the idea that cannabinoids might also have anti-cancer properties is still a developing area of research. Some early studies in cell cultures and animal models have shown that cannabinoids may inhibit the growth of certain cancer cells, induce apoptosis (programmed cell death), and prevent the spread of tumors.

For example, this study found that THC reduced the growth of glioma cells (a type of brain cancer) in mice, while other research has suggested that cannabinoids may slow the progression of breast cancer, prostate cancer, and lung cancer. Additionally, CBD has been investigated for its potential to reduce the invasiveness of cancer cells and enhance the efficacy of traditional chemotherapy agents.

However, while these findings are encouraging, they are still largely preclinical. Human trials are limited, and much more research is needed to determine whether cannabis can be an effective treatment for cancer itself beyond its role in symptom management. Nevertheless, these early studies have sparked excitement among researchers and patients alike.


The Current Legal Landscape

As with any discussion of cannabis, the legal landscape plays a significant role in its use, particularly in medical settings like oncology. In the United States, cannabis remains illegal at the federal level, classified as a Schedule I drug alongside substances like heroin and LSD. This classification makes it difficult for researchers to conduct large-scale clinical trials, further delaying the exploration of cannabis in cancer treatment.

That said, individual states have taken matters into their own hands. As of 2024, 38 states and the District of Columbia have legalized medical marijuana, allowing cancer patients to access cannabis for symptom relief. However, the specifics of these laws vary from state to state, with some requiring patients to have a medical marijuana card and others allowing over-the-counter access.


Cannabis & Oncologists

While patients are increasingly turning to cannabis to manage their cancer symptoms, oncologists remain divided on the subject or simply in the dark. 

In March 2024, The American Society of Clinical Oncology (ASCO) published the first clinical guidelines on cannabis use, bluntly stating: “Cannabis and/or cannabinoid access and use by adults with cancer has outpaced the science supporting their clinical use.”

One of the most urgent challenges arising from this lack of scientific evidence, as several studies have shown, is that oncologists and other providers feel unprepared to discuss medical cannabis with their patients. 

Clinicians entering the newly legalized and evolving cannabis and psychedelic health industry must receive specialized training to understand the complexities, risks, and benefits of these treatments. Cannabis is a nuanced medicine, and dosing and consumption methods vary greatly based on individual patient history and symptoms. 

These gaps highlight the need for more education and research. As the stigma surrounding cannabis continues to fade, more healthcare professionals will likely begin to see cannabis as a valuable tool in the oncology toolkit. However, for now, patients and doctors must work together to navigate the complex and sometimes confusing landscape of medical cannabis.


Risks & Considerations

Despite its potential benefits, cannabis is not a one-size-fits-all solution. Like any treatment, it comes with risks and considerations that must be carefully weighed. THC, for example, can cause psychoactive effects, including anxiety, paranoia, and impaired cognitive function—particularly at high doses. For cancer patients already dealing with psychological stress, this can be a drawback.

Additionally, cannabis may interact with certain medications, including chemotherapy drugs, potentially altering their efficacy. Patients should always consult with their healthcare providers before incorporating cannabis into their treatment plan to ensure it’s safe and appropriate for their specific case.


The Future of Cannabis in Cancer Care

The intersection of cannabis and oncology is a rapidly evolving field, with new research emerging every year. As legalization continues to expand and stigma fades, we can expect to see more studies exploring the full potential of cannabis in cancer treatment. This will likely lead to better guidance for patients and healthcare providers alike, ensuring that cannabis is used safely and effectively.

For now, cannabis remains a complementary therapy in oncology, offering relief for symptoms like pain, nausea, and anxiety. However, the future may hold even more promising developments as researchers continue to unlock the potential of this ancient plant.

If you’re a healthcare leader, cannabis entrepreneur, or advocate looking to shape the future of medicine, apply to join Rolling Stone Culture Council. We’re an exclusive community of industry leaders driving change and challenging old paradigms. From cannabis and oncology to technology and wellness, we’re shaping the future—together.


Rolling Stone Culture Council is an invitation-only community for innovators and tastemakers on the cutting edge of what’s new in culture. Learn more.